|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.640 USD | -2.33% |
|
-2.43% | +70.62% |
| 07-13 | Stifel Nicolaus Initiates Coverage on Candel Therapeutics With Buy Rating, $22 Price Target | MT |
| 06-30 | Candel Therapeutics Stock Gains on Launch of Phase 3 Trial for Lung-Cancer Drug | DJ |
| Market Cap | 723M 632M 583M 536M 1.02B 69.59B 1.03B 6.96B 2.73B 34.01B 2.72B 2.66B 117B | P/E 2026 * |
-10.9x | P/E 2027 * | -13.9x |
|---|---|---|---|---|---|
| Enterprise Value | 723M 632M 583M 536M 1.02B 69.59B 1.03B 6.96B 2.73B 34.01B 2.72B 2.66B 117B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 16.9x |
| Free-Float |
84.33% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Candel Therapeutics, Inc.
| 1 day | -2.33% | ||
| 1 week | -2.43% | ||
| Current month | -6.41% | ||
| 1 month | +12.62% | ||
| 3 months | +87.18% | ||
| 6 months | +62.29% | ||
| Current year | +70.62% |
| 1 week | 9.19 |  | 10.16 |
| 1 month | 7.93 | | 11.36 |
| Current year | 4.44 | | 11.36 |
| 1 year | 4.35 | | 11.36 |
| 3 years | 0.66 | | 14.6 |
| 5 years | 0.66 | | 14.78 |
| 10 years | 0.66 | | 14.78 |
| Manager | Title | Age | Since |
|---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 66 | 2020-08-31 |
Charles Schoch
DFI | Director of Finance/CFO | 41 | 2024-01-11 |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 58 | 2022-03-01 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 70 | 2022-08-07 |
Edward Benz
BRD | Director/Board Member | 80 | 2017-08-31 |
Paul Manning
CHM | Chairman | 70 | 2021-07-14 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 07-05 | Free | Executive/Senior Manager | 285,000 | 0.3890% | ||
| 06-29 | Free | Chairman | 2,199 | 0.0030% | ||
| 06-29 | Free | Director | 381 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.33% | -2.43% | +54.24% | +703.33% | 723M | |
| -0.17% | +1.22% | +2.98% | +6.80% | 50.35B | |
| -0.29% | -2.81% | +387.81% | +593.12% | 39.32B | |
| -0.49% | +1.48% | +31.16% | -6.58% | 34.69B | |
| +1.53% | +3.11% | +15.41% | +57.28% | 34.08B | |
| +1.68% | -1.40% | +4.23% | +27.34% | 26.63B | |
| +1.13% | -3.11% | - | - | 16.49B | |
| -1.29% | -0.52% | +69.24% | +113.95% | 15.31B | |
| +0.43% | +0.55% | +15.19% | +17.46% | 13.8B | |
| +2.45% | +3.99% | +18.20% | -29.77% | 12.87B | |
| Average | +0.33% | -0.34% | +66.50% | +164.77% | 24.43B | |
| Weighted average by Cap. | +0.48% | -0.32% | +81.93% | +123.94% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 42.84M 37.45M 34.55M 31.76M 60.17M 4.12B 61.2M 412M 162M 2.01B 161M 157M 6.94B |
| Net income | -61.55M -53.81M -49.64M -45.63M -86.46M -5.92B -87.94M -593M -233M -2.89B -231M -226M -9.98B | -54.13M -47.32M -43.65M -40.13M -76.03M -5.21B -77.33M -521M -204M -2.55B -203M -199M -8.77B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-15 | US$9.640 | -2.33% | 1,147,552 |
| 26-07-14 | US$9.870 | +2.39% | 1,425,091 |
| 26-07-13 | US$9.640 | +1.58% | 1,627,557 |
| 26-07-10 | US$9.490 | -4.04% | 1,190,965 |
| 26-07-09 | US$9.890 | +0.10% | 1,101,829 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CADL Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
